TITLE

Five Years Later: The Impact of Personal Genomics Study

AUTHOR(S)
CARERE, DEANNA ALEXIS
PUB. DATE
October 2016
SOURCE
GeneWatch;Oct-Dec2016, Vol. 29 Issue 3, p4
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses state of the direct-to-consumer (DTC) genetic testing industry. It discusses launch of the Impact of Personal Genomics (PGen) Study to provide the before and after survey of DTC genetic testing customers. It mentions blocking over-the-counter sales of DTC genetic tests from Pathway Genomics firm by Food and Drug Administration (FDA).
ACCESSION #
119908468

 

Related Articles

  • From the Lab to the Market. PHILLIPS, ANDELKA M.; CHARBONNEAU, JAN // GeneWatch;Oct-Dec2016, Vol. 29 Issue 3, p7 

    The article discusses consumer understanding and direct-to-consumer genetic testing. It discusses launch of the Impact of Personal Genomics (PGen) Study to provide the before and after survey of DTC genetic testing customers. It mentions blocking over-the-counter sales of DTC genetic tests from...

  • Pathway Genomics Obtains FDA Registration.  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p268 

    The article reports on the classification and registration of Pathway Genomics Corp.'s proprietary saliva collection kit as a Class I exempt device approved by the U.S. Food & Drug Administration (FDA). It notes that the kit helps patients and physicians with an effective and safe method of...

  • FDA raps liquid biopsy firm.  // Nature Biotechnology;Nov2015, Vol. 33 Issue 11, p1117 

    The article reports on the concerns expressed by the US Food and Drug Administration (FDA) who stepped into the laboratory-developed tests sphere by sending a letter to the pharmaceutical Pathway Genomics, for marketing the unapproved genetic test CancerIntercept Detect directly to consumers.

  • American Clinical Laboratory Association Welcomes Pathway Genomics as New Member.  // Biomedical Market Newsletter;2/21/2012, Vol. 21, p1 

    The article informs that Pathway Genomics Corp. has received membership in the American Clinical Laboratory Association (ACLA), non profit organization. ACLA is involved in promoting public awareness about thevalue of laboratory services in preventing illness, diagnosing disease, and monitoring...

  • Pathway Fit(r) Genetic Test Featured on Discovery Fit & Health's Original Web Series Transformation Diaries.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article informs that the premier genetic testing service, Pathway Fit from Pathway Genomics Corp. featured on the web series Transformation Diaries. It informs that the web series mentions about four women on their journeys to accomplishing four different goals. It also informs about Pathway...

  • Direct-access genetic testing: the view from Europe. Kricka, Larry J.; Fortina, Paolo; Mai, Yuan; Patrinos, George P. // Nature Reviews Genetics;Oct2011, Vol. 12 Issue 10, p670 

    The article discusses the comparison of direct-to-consumer (DTC) genetic testing in Europe and in North America. It says that DTC genetic testing in the U.S. has received an intense examination in terms of legality, reliability, and benefits to the patients. It mentions that in Europe, it is...

  • FDA reopens DTC gene test comment period.  // Medical Device Daily;4/8/2011, Vol. 15 Issue 68, p7 

    The article reports on the decision of the U.S. Food and Drug Administration (FDA) to reopen the comment period for its proposal to implement regulatory requirements on companies that are offering direct-to-consumer genetic tests in April 2011.

  • FDA resists regulatory role in gene tests. Wadman, Meredith // Nature;11/14/1996, Vol. 384 Issue 6605, p101 

    Discusses the controversy surrounding the decision by a government-sponsered task force to recommend that the US Food and Drug Administration (FDA) regulate genetic tests. The task force comprised of the National Institutes of Health and the Department of Energy Task Force on Genetic Testing;...

  • The PPA Blues. Smith, Ian K. // Time International (South Pacific Edition);10/30/2000, Issue 43, p77 

    Reports on the health concerns surrounding the drug Phenylpropanolamine (PPA), a common ingredient in over-the-counter pharmaceuticals. Research that has been conducted on the product; Recommendation from the United States Food and Drug Administration that the drug be banned; What effect the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics